These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1412788

  • 1. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA.
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract] [Full Text] [Related]

  • 2. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
    Masri MA.
    Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
    [No Abstract] [Full Text] [Related]

  • 3. Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.
    Lagodzinski Z, Górski A, Wasik M.
    Immunology; 1990 Sep; 71(1):148-50. PubMed ID: 1698713
    [Abstract] [Full Text] [Related]

  • 4. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU, Kurrle R.
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract] [Full Text] [Related]

  • 5. Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitor.
    Påhlman C, Malm H, Qi Z, Veress B, Ferguson D, Bundick R, Murray C, Donald D, Ekberg H.
    Transplantation; 2008 Oct 27; 86(8):1135-8. PubMed ID: 18946353
    [Abstract] [Full Text] [Related]

  • 6. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J, Xia J, Zhang K, Xu L.
    J Surg Res; 2009 Nov 27; 157(1):81-90. PubMed ID: 19577762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide.
    Eng CP, Gullo-Brown J, Chang JY, Sehgal SN.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 1):868-9. PubMed ID: 1990708
    [No Abstract] [Full Text] [Related]

  • 9. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M, Okamoto S, Streilein JW, Jiang LQ.
    Invest Ophthalmol Vis Sci; 1997 Sep 27; 38(10):2152-60. PubMed ID: 9331279
    [Abstract] [Full Text] [Related]

  • 10. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU, Schwab W, Ruuth E, Kurrle R.
    Transplant Proc; 1996 Dec 27; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of immunosuppressive drugs in xenografting.
    Thomas FT, DeMasi RJ, Araneda D, Marchman W, Alqaisi M, Larkin EW, Condie RM, Carobbi A, Thomas JM.
    Transplant Proc; 1990 Jun 27; 22(3):1083-5. PubMed ID: 1693452
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU, Kurrle R.
    Int J Tissue React; 1997 Jun 27; 19(3-4):149-56. PubMed ID: 9506316
    [Abstract] [Full Text] [Related]

  • 13. A novel series of low molecular weight immunosuppressive agents.
    Ocain TD, Bastos CM, Gordon KA, Granstein RD, Jenson JC, Jones B, McAuliffe DJ, Newcomb JR.
    Transplant Proc; 1996 Dec 27; 28(6):3032-4. PubMed ID: 8962176
    [No Abstract] [Full Text] [Related]

  • 14. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 15. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC.
    J Heart Lung Transplant; 1995 Jan 18; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [Abstract] [Full Text] [Related]

  • 16. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
    Collins BH, Areford ML, Fabian MA, Jaffee BD, Bollinger RR.
    Transplant Proc; 1993 Jun 18; 25(3 Suppl 2):37-9. PubMed ID: 8516941
    [No Abstract] [Full Text] [Related]

  • 17. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S, Kasraie A, Une S, Ohtsuka S, Smith CV, Mullen Y.
    Cell Transplant; 2001 Jun 18; 10(7):639-44. PubMed ID: 11714199
    [Abstract] [Full Text] [Related]

  • 18. New 20-epi-vitamin D3 analogs: immunosuppressive effects on skin allograft survival.
    Veyron P, Pamphile R, Binderup L, Touraine JL.
    Transplant Proc; 1995 Feb 18; 27(1):450. PubMed ID: 7879058
    [No Abstract] [Full Text] [Related]

  • 19. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
    Schorlemmer HU, Seiler FR, Bartlett RR.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 1):763-7. PubMed ID: 8438472
    [No Abstract] [Full Text] [Related]

  • 20. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS, Nogueira-Martins MF, Silva HT, Pestana JO, Bueno V.
    Transplant Proc; 2004 May 18; 36(4):1015-7. PubMed ID: 15194353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.